Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04368663
NA

The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis

Sponsor: Showa Inan General Hospital

View on ClinicalTrials.gov

Summary

The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.

Official title: The Beneficial Effect of the Traditional Japanese Medicine, Keishi-ka-shakuyaku-daio-to(TJ-134)for Patients With Symptomatic Pneumatosis Cystoides

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2020-05-01

Completion Date

2026-12-31

Last Updated

2025-05-15

Healthy Volunteers

No

Interventions

DRUG

Japanese traditional medicine group

TJ-134 (7.5g/day) or lactomin (3g/day) is administered for 8 weeks.

Locations (1)

Showa Inan General hospital

Komagane, Nagano, Japan